The Efficacy and Tolerability of Rufinamide in Intractable Pediatric Epilepsy
Jae Yeon Kim, Cha Gon Lee, Hee Joon Yu, Sook Hyun Nam, Jeehun Lee, Munhyang Lee
J Epilepsy Res. 2012;2(2):33-37.     DOI: https://doi.org/10.14581/jer.12009
Citations to this article as recorded by Crossref logo
Modern approaches in the treatment of Lennox–gastaut syndrome (a review of literature)
К. Yu. Мukhin, О. A. Pylaeva
Russian Journal of Child Neurology.2018; 13(2): 34.     CrossRef
Rufinamide (inovelon) in the treatment of Lennox–gastaut syndrome (a review of literature)
К. Yu. Мukhin, О. A. Pylaeva
Russian Journal of Child Neurology.2018; 13(2): 20.     CrossRef
Long-term safety and seizure outcome in Japanese patients with Lennox–Gastaut syndrome receiving adjunctive rufinamide therapy: An open-label study following a randomized clinical trial
Yoko Ohtsuka, Harumi Yoshinaga, Yukiyoshi Shirasaka, Rumiko Takayama, Hiroki Takano, Kuniaki Iyoda
Epilepsy Research.2016; 121: 1.     CrossRef
Treatment of Adults with Lennox–Gastaut Syndrome: Further Analysis of Efficacy and Safety/Tolerability of Rufinamide
Rob McMurray, Pasquale Striano
Neurology and Therapy.2016; 5(1): 35.     CrossRef
Effectiveness and safety of rufinamide at treatment of epilepsy with complications and drug-resistant epilepsy (according to meta-analysis data)
P. V. Mazin, I. V. Sheshunov, Yu. V. Kislitsyn, N. K. Mazina
Zhurnal nevrologii i psikhiatrii im. S.S. Korsakov.2016; 116(8): 40.     CrossRef
Successful Treatment of Refractory Seizures With Rufinamide in Children With Schizencephaly
Alberto Verrotti, Giulia Loiacono, Alessandra Rossi, Armando Tartaro, Andrea Delli Pizzi, Giangennaro Coppola
Journal of Child Neurology.2015; 30(8): 1079.     CrossRef